Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of omalizumab, compared to placebo, on
clinically significant asthma exacerbation rates in adolescents and adults with asthma.